Literature DB >> 9560867

Stressful life events and smoking were associated with Graves' disease in women, but not in men.

K Yoshiuchi1, H Kumano, S Nomura, H Yoshimura, K Ito, Y Kanaji, Y Ohashi, T Kuboki, H Suematsu.   

Abstract

OBJECTIVE: Although psychological stress and smoking have been proposed as contributing factors to Graves' disease, their independent roles in the pathogenesis of this disease have not been determined. We assessed the association between Graves' disease and psychological stress and smoking by using multivariate analysis.
METHODS: By a matched case-control method, we investigated the association between Graves' disease and stressful life events, daily hassles, smoking, drinking habits, coping skills, and social support in 228 patients (182 women and 46 men) with newly diagnosed Graves' disease; we used the conditional maximum likelihood method.
RESULTS: After data were adjusted for daily hassles, smoking, drinking habits, social support, and coping skills, we found that stressful life events were significantly associated with the risk of Graves' disease in women. The relative risk was 7.7 for women with the highest stress score compared with women with the lowest stress score (95% confidence interval, 2.2 to 27, p for trend < .001). Smoking was also independently associated with the risk of Graves' disease in women. The relative risk for women with the highest number group compared with women with the lowest number group for smoking cigarettes was 5.1 (95% confidence interval, 1.0 to 27; p for trend < .001). These factors were not significantly associated with Graves' disease in men.
CONCLUSIONS: Psychological stress and smoking were associated with Graves' disease in women, but not in men.

Entities:  

Mesh:

Year:  1998        PMID: 9560867     DOI: 10.1097/00006842-199803000-00013

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  12 in total

Review 1.  Relationship between cigarette smoking and Graves' ophthalmopathy.

Authors:  L Hegediüs; T H Brix; P Vestergaard
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

2.  Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves' disease.

Authors:  Roberto Vita; Daniela Lapa; Francesco Trimarchi; Salvatore Benvenga
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

3.  Soluble CD4 concentrations predict relapse of post-partum thyroiditis.

Authors:  C Balázs; N R Farid
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

4.  Does smoking increase relapse rates in Graves' disease?

Authors:  L E Kimball; E Kulinskaya; B Brown; C Johnston; N R Farid
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

Review 5.  The risk factors for Graves' ophthalmopathy.

Authors:  Jiamin Cao; Yuhe Su; Zhuokun Chen; Chen Ma; Wei Xiong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-11-17       Impact factor: 3.117

6.  Certain HLA alleles are associated with stress-triggered Graves' disease and influence its course.

Authors:  Roberto Vita; Daniela Lapa; Francesco Trimarchi; Giuseppe Vita; Poupak Fallahi; Alessandro Antonelli; Salvatore Benvenga
Journal:  Endocrine       Date:  2016-03-07       Impact factor: 3.633

7.  The etiology of autoimmune thyroid disease: a story of genes and environment.

Authors:  Yaron Tomer; Amanda Huber
Journal:  J Autoimmun       Date:  2009 May-Jun       Impact factor: 7.094

8.  Stress and hormones.

Authors:  Salam Ranabir; K Reetu
Journal:  Indian J Endocrinol Metab       Date:  2011-01

9.  The thyroid function of Graves' disease patients is aggravated by depressive personality during antithyroid drug treatment.

Authors:  Atsushi Fukao; Junta Takamatsu; Sumihisa Kubota; Akira Miyauchi; Toshiaki Hanafusa
Journal:  Biopsychosoc Med       Date:  2011-08-09

10.  Prevalence and risk factors for thyroid eye disease among Korean dysthyroid patients.

Authors:  Kyung In Woo; Yoon-Duck Kim; Sang Yeul Lee
Journal:  Korean J Ophthalmol       Date:  2013-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.